Revance Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1M | 120k | 8.79 |
| 2023-09-30 | $1.4M | 118k | 11.47 |
| 2023-06-30 | $2.9M | 116k | 25.31 |
| 2023-03-31 | $3.4M | 107k | 32.21 |
| 2022-12-31 | $1.9M | 103k | 18.46 |
| 2022-09-30 | $2.5M | 93k | 27.00 |
| 2022-06-30 | $1.2M | 83k | 13.82 |
| 2022-03-31 | $1.6M | 81k | 19.51 |
| 2021-12-31 | $1.3M | 82k | 16.32 |
| 2021-09-30 | $2.4M | 86k | 27.86 |
| 2021-06-30 | $2.4M | 83k | 29.64 |
| 2021-03-31 | $2.5M | 88k | 27.95 |
| 2020-12-31 | $2.7M | 96k | 28.34 |
| 2020-09-30 | $2.2M | 88k | 25.14 |
| 2020-06-30 | $2.5M | 102k | 24.42 |
| 2020-03-31 | $1.2M | 82k | 14.80 |
| 2019-12-31 | $1.1M | 68k | 16.23 |
| 2019-09-30 | $867k | 67k | 13.01 |
| 2019-06-30 | $822k | 63k | 12.97 |
| 2019-03-31 | $774k | 49k | 15.76 |
| 2018-12-31 | $872k | 43k | 20.12 |
| 2018-09-30 | $729k | 29k | 24.86 |
| 2018-06-30 | $863k | 32k | 27.44 |
| 2018-03-31 | $744k | 24k | 30.79 |
| 2017-12-31 | $761k | 21k | 35.77 |
| 2017-09-30 | $705k | 26k | 27.54 |
| 2017-06-30 | $669k | 25k | 26.41 |
| 2017-03-31 | $477k | 23k | 20.80 |
| 2016-12-31 | $434k | 21k | 20.68 |
| 2016-09-30 | $315k | 19k | 16.21 |
| 2016-06-30 | $259k | 19k | 13.61 |
| 2016-03-31 | $290k | 17k | 17.46 |
| 2015-12-31 | $547k | 16k | 34.14 |
| 2015-09-30 | $412k | 14k | 29.75 |
| 2015-06-30 | $425k | 13k | 31.96 |
| 2014-06-30 | $213k | 6.3k | 33.95 |